GCMD Library

Puberty and growth in patients with pediatric intestinal failure

Katherine Culbreath, MD, Gregory Keefe, MD, Steven J. Staffa, MS, Nicole Wynne, BS, Frances Grimstad, MD MS, Lissette Jimenez, MD MPH, Tom Jaksic, MD PhD, Biren P. Modi, MD MPH

Puberty and growth in patients with pediatric intestinal failure - medical infographic

Description

Background

Pediatric intestinal failure (PIF) affects nutrition, metabolism, and endocrine development, but its downstream impact on puberty is unknown.

Methods

A retrospective review was performed of patients age >8 years with PIF managed at an intestinal rehabilitation program. Outcomes of interest were peak height velocity (PHV), age at PHV, and age at pubertal onset (Tanner stage 2). Outcomes were stratified by sex and compared to established norms.

Results

Of 110 patients with PIF, 54.5% were male. Compared to the CDC 50th percentile, PHV in PIF patients was similar for females (8.09±2.36 vs. 7.37 cm/yr;p = 0.23) but significantly higher for males (9.27±2.56 vs. 7.91 cm/yr;p = 0.038). Age at PHV in PIF patients was significantly younger for both males (12.31±2.14 vs. 13.38 years;p = 0.049) and females (10.70±1.06 vs. 11.71 years;p = 0.001). PIF patients reached pubertal onset earlier than published norms; this was significant for males (12.41±1.80 vs. 13.44 years;p = 0.014), but not for females (10.45±1.81 vs. -11.15 years;p = 0.13). The mean height-for-age Z-score was -1.2, with 20% of patients having a Z-score less than -2.

Conclusions

Pubertal onset and growth are neither delayed nor diminished in patients with PIF. The high incidence of short stature, however, highlights the importance of optimizing prepubertal linear growth to attain full height potential.

Open file

Keywords

Hashtags

Comments (0)

Puberty and growth in patients with pediatric intestinal failure - medical infographic